Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients

Medical Microbiology and Immunology

Volumn 201, Issue 3, 2012, Pages 297-302

  Ott, Undine ^a   Sauerbrei, Andreas ^b   Lange, Jeannette ^b   Schäfler, Anna ^b   Walther, Mario ^b   Wolf, Gunter ^b   Wutzler, Peter ^b   Zell, Roland ^b   Krumbholz, Andi ^b  

^a KfH Nierenzentrum   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Hemodialysis; Influenza; Kidney transplantation; Pandemic H1N1; Seroprotection; Vaccination

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG FEVER; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GRAFT RECIPIENT; HEMAGGLUTINATION INHIBITION TEST; HEMODIALYSIS PATIENT; HUMAN; INFECTION PREVENTION; INFECTION RATE; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VACCINATION; INJECTION SITE PAIN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEASONAL INFLUENZA; SINGLE DRUG DOSE; VIRUS STRAIN;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL DIALYSIS; SEASONS; VACCINATION; YOUNG ADULT;

EID: 84864350193     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-012-0231-8     Document Type: Article

References (37)

1. Vilchez RA, McCurry K, Dauber J, Lacono A, Griffth B, Fung J, Kusne S (2002) Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2:287-291
2. Weinstock DM, Gubareva LV, Zuccotti G (2003) Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient. N Engl J Med 348:867-868
3. Kunisaki KM, Janoff EN (2009) Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 9:493-504
4. Marcelli D, Marelli C, Richards N (2009) Influenza A(H1N1)v pandemic in the dialysis population: first wave results from an international survey. Nephrol Dial Transplant 24:3566-3572
5. Smud A, Nagel CB, Madsen E, Rial Mdel C, Barcan LA, Gomez AA, Martinoia AG, Bangher MC, Altclas JD, Salgueira CC, Temporiti E, Bonvehi PE, Enriquez N, Efron ED, Bibolini JE, Lattes R (2010) Pandemic influenza A/H1N1 virus infection in solid organ transplant recipients: a multicenter study. Transplantation 90:1458-1462
6. Danzinger-Isakov L, Kumar D (2009) Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 9(Suppl 4):S258-S262
7. Kumar D, Morris MI, Kotton CN, Fischer SA, Michaels MG, Allen U, Blumberg EA, Green M, Humar A, Ison MG (2010) Guidance on novel influenza A/H1N1 in solid organ transplant recipients. Am J Transplant 10:18-25
8. WHO (2009) WHO recommendations on pandemic (H1N1) 2009 vaccines
9. Brakemeier S, Schweiger B, Lachmann N, Glander P, Schonemann C, Diekmann F, Neumayer HH, Budde K (2012) Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix(R)) in renal transplant recipients. Nephrol Dial Transplant 27:423-428
10. Hoelscher M, Gangappa S, Zhong W, Jayashankar L, Sambhara S (2008) Vaccines against epidemic and pandemic influenza. Expert Opin Drug Deliv 5:1139-1157
11. Duchini A, Goss JA, Karpen S, Pockros PJ (2003) Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. Clin Microbiol Rev 16:357-364
12. Boehmer LM, Waqar SN, Govindan R (2010) Influenza vaccination in patients with cancer: an overview. Oncology 24:1167-1170 (Williston Park)
13. Versluis DJ, Beyer WE, Masurel N, Wenting GJ, Weimar W (1986) Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation 42:376-379
14. Sanchez-Fructuoso AI, Prats D, Naranjo P, Fernandez-Perez C, Gonzalez MJ, Mariano A, Gonzalez J, Figueredo MA, Martin JM, Paniagua V, Fereres J, Gomez de la Concha E, Barrientos A (2000) Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: mycophenolate versus azathioprine. Transplantation 69:436-439
15. Candon S, Thervet E, Lebon P, Suberbielle C, Zuber J, Lima C, Charron D, Legendre C, Chatenoud L (2009) Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients. Am J Transplant 9:2346-2354
16. Gangappa S, Kokko KE, Carlson LM, Gourley T, Newell KA, Pearson TC, Ahmed R, Larsen CP (2008) Immune responsiveness and protective immunity after transplantation. Transpl Int 21:293-303
17. WHO (2009) World now at the start of 2009 influenza pandemic
18. Broadbent AJ, Subbarao K (2011) Influenza virus vaccines: lessons from the 2009 H1N1 pandemic. Curr Opin Virol 1:254-262
19. EMEA (2009) European medicines agency recommends authorization of two vaccines for influenza pandemic (H1N1) 2009. European Medicines Agency, London
20. Krumbholz A, Lange J, Durrwald R, Hoyer H, Bengsch S, Wutzler P, Zell R (2010) Prevalence of antibodies to swine influenza viruses in humans with occupational exposure to pigs, Thuringia, Germany, 2008-2009. J Med Virol 82:1617-1625
21. FDA (2007) Guidance for industry: clinical data needed to support the licensure of pandemic influenza vaccines
22. Allwinn R, Geiler J, Berger A, Cinatl J, Doerr HW (2010) Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans? Med Microbiol Immunol 199:117-121
23. Kumar D, Michaels MG, Morris MI, Green M, Avery RK, Liu C, Danziger-Isakov L, Stosor V, Estabrook M, Gantt S, Marr KA, Martin S, Silveira FP, Razonable RR, Allen UD, Levi ME, Lyon GM, Bell LE, Huprikar S, Patel G, Gregg KS, Pursell K, Helmersen D, Julian KG, Shiley K, Bono B, Dharnidharka VR, Alavi G, Kalpoe JS, Shoham S, Reid GE, Humar A (2010) Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 10:521-526
24. Hurst FP, Lee JJ, Jindal RM, Agodoa LY, Abbott KC (2011) Outcomes associated with influenza vaccination in the first year after kidney transplantation. Clin J Am Soc Nephrol: CJASN 6:1192-1197
25. Gilbertson DT, Unruh M, McBean AM, Kausz AT, Snyder JJ, Collins AJ (2003) Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int 63:738-743
26. Crespo M, Collado S, Mir M, Cao H, Barbosa F, Serra C, Hidalgo C, Faura A, Montero M, Garcia de Lomas J, Horcajada JP, Puig JM, Pascual J (2011) Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patients. Clin J Am Soc Nephrol: CJASN 6:2208-2214
27. Dikow R, Eckerle I, Ksoll-Rudek D, Hampel H, Schwenger V, Zeier M, Schnitzler P, Sommerer C (2011) Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for pandemic influenza A(H1N1): a nonrandomized trial. Am J Kidney Dis 57:716-723
28. Broeders NE, Hombrouck A, Lemy A, Wissing KM, Racape J, Gastaldello K, Massart A, Van Gucht S, Weichselbaum L, De Mul A, Brochier B, Thomas I, Abramowicz D (2011) Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study. Clin J Am Soc Nephrol: CJASN 6:2573-2578
29. Temiz G, Kasifoglu N, Kiris A, Ozturk S, Sahin G, Yalcin AU, Us T (2010) Immune response after a single vaccination against 2009 influenza A H1N1 in hemodialysis patients. Ren Fail 32:716-720
30. Kelen K, Ferenczi D, Jankovics I, Varga M, Molnar MZ, Sallay P, Reusz G, Langer RM, Pasti K, Gerlei Z, Szabo AJ (2011) H1N1 vaccination in pediatric renal transplant patients. Transplant Proc 43:1244-1246
31. Meyer S, Adam M, Schweiger B, Ilchmann C, Eulenburg C, Sattinger E, Runte H, Schluter M, Deuse T, Reichenspurner H, Costard-Jackle A (2011) Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients. Transplantation 91:1031-1035
32. Crum-Cianflone NF, Iverson E, Defang G, Blair PJ, Eberly LE, Maguire J, Ganesan A, Faix D, Duplessis C, Lalani T, Whitman T, Brandt C, Macalino G, Millar EV, Burgess T (2011) Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults. Vaccine 29:3183-3191
33. Paget J, Marquet R, Meijer A, van der Velden K (2007) Influenza activity in Europe during eight seasons (1999-2007): an evaluation of the indicators used to measure activity and an assessment of the timing, length and course of peak activity (spread) across Europe. BMC Infect Dis 7:141
34. Morelon E, Pouteil Noble C, Daoud S, Cahen R, Goujon-Henry C, Weber F, Laurent PE, Kaiserlian D, Nicolas JF (2010) Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination. Vaccine 28:6885-6890
35. Sauerbrei A, Schmidt-Ott R, Hoyer H, Wutzler P (2009) Seroprevalence of influenza A and B in German infants and adolescents. Med Microbiol Immunol 198:93-101
36. Grund S, Adams O, Wahlisch S, Schweiger B (2009) Comparison of hemagglutination inhibition assay, an ELISA-based microneutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1virus. J Virol Methods 171(2011):369-373
37. Remarque EJ, de Bruijn IA, Boersma WJ, Masurel N, Ligthart GJ (1998) Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay. J Med Virol 55:82-87